Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Automated synthesis of Ga-68/Lu-177-PSMA on the Trasis miniAllinOne

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Radiosynthesis and preclinical evaluation of [C-11]Cimbi-701-Towards the imaging of cerebral 5-HT7 receptors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Evaluation of [18 F]2FP3 in pigs and non-human primates

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Factors associated with melanoma-related limb lymphoedema

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Observer Agreement and Accuracy of F-18-Sodium Fluoride PET/CT in the Diagnosis of Bone Metastases in Prostate Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Prostate-specific membrane antigen (PSMA)-based radioligands for positron emission tomography (PET)/computed tomography (CT) studies represent the gold standard for detection of recurrent prostate cancer (PCa). [ 68Ga]PSMA-HBED-CC is a PET radiotracer suitable for detection of PCa, and its clinical use has become widespread over the last few years. In this contribution, we detail our GMP-compliant production of [ 68Ga]PSMA-HBED-CC using the Trasis miniAllinOne radiosynthesizer and report synthetic and clinical data for the first 100 productions of 2019. Additionally, we detail our efforts towards a GMP-compliant production of the radiotherapeutic [ 177Lu]PSMA-I&T using the same synthesis module. PSMA-based radioligand therapy (RLT) offers a possible future treatment in cases of metastatic castration-resistant PCa, and GMP-compliant routine production methods are therefore called for. This report highlights how PSMA-based agents for theranostic purposes can be conveniently produced at a single radiochemistry Good Manufacturing Practice (GMP) site, thereby facilitating optimized detection and treatment of PCa.

OriginalsprogEngelsk
TidsskriftJournal of Labelled Compounds and Radiopharmaceuticals
Vol/bind63
Udgave nummer8
Sider (fra-til)393-403
Antal sider11
ISSN0362-4803
DOI
StatusUdgivet - 30 jun. 2020

ID: 59823483